
Loading, please wait...

Loading, please wait...

The Supreme Court of India recently rejected a plea requesting a shift in the NEET re-examination format. Specifically, the petition sought to move the upcoming June 21 test to a computer-based mode. However, a vacation bench of Justices PS Narasimha and Aravind Kumar refused this transition request. Consequently, the test will proceed in its offline, pen-and-paper format as planned.
The apex court pointed out significant practical challenges during the hearing on Monday. Justice PS Narasimha observed that the NTA is already facing intense pressure following the cancellation of the May 3 exam. Therefore, introducing a new computer-based system at this late stage would disrupt the process further. Additionally, the bench highlighted that the court had already dismissed previous similar pleas. Thus, the court decided to defer the matter to July.
RJD MP Sudhakar Singh originally sought sweeping reforms through his petition after widespread paper leaks. On May 12, the NTA cancelled the initial exam held on May 3 due to these integrity issues. Currently, the Central Bureau of Investigation is conducting a thorough inquiry into the paper leak. Because of this chaos, the petitioner argued that a secure computer-based system would minimize future security risks. Furthermore, they requested a time-bound roadmap to develop digital infrastructure for all future national entrance exams.
Q1: Why did the Supreme Court refuse to conduct the NEET-UG 2026 re-examination in CBT mode?
The court pointed out that changing the exam mode at this stage poses extreme practical difficulties. Additionally, the National Testing Agency is already dealing with massive organizational and administrative pressure.
Q2: When is the rescheduled NEET-UG 2026 exam taking place?
The re-test remains scheduled for June 21, 2026, and the NTA will conduct it using the offline, pen-and-paper format.
Q3: What was the origin of the plea seeking a computer-based format?
The plea followed the cancellation of the initial May 3 examination due to widespread paper leak allegations. The petitioner argued that a digital CBT mode would provide better security and minimize leak risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Supreme Court of India has declined a plea to conduct the June 21 NEET-UG 2026 re-test in a computer-based format, keeping the pen-and-paper mode....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today